High levels of PD-L1 expression have been associated with worse OS of early TNBC and NSCLC patients and with shorter PFS of metastatic breast cancer (MBC) patients [35,36,37,38,39]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.